Falsified medicines and broken cold chains — solved in one tag
From counterfeit Ozempic in the US supply chain to INTERPOL's Operation Pangea seizures, fake and temperature-compromised medicines are a patient-safety and brand crisis. TAGUARD authenticates every pack and proves it stayed in-spec.
What's hurting pharma right now
Counterfeit GLP-1s and biologics
Fake Ozempic and tirzepatide products have copied packaging, labels and needles well enough to trigger FDA alerts and criminal charges in 2026.
Falsified-medicine surges
INTERPOL's Operation Pangea XVIII drove USD 15.5M in seizures across dozens of countries — branded pharma is the primary target.
Cold-chain excursions
Vaccines, mRNA products and biologics fail silently when they drift outside 2–8 °C in transit or storage, especially in low-infrastructure markets.
The TAGUARD remedy
Defense-in-depth that complements your existing serialization and GDP compliance — without special reader hardware at the edge.
Copy-resistant pack authentication
ChaosMark adds secure NFC + cryptographic verification to cartons and vials, so pharmacists and patients confirm authenticity in a tap.
Continuous cold-chain proof
TAG K5PT BLE beacons log temperature and alert on 2–8 °C excursions across distribution; TAG GT01 gateways capture the data in real time.
Distribution intelligence
See where genuine product travels, catch diversion, and generate audit-ready chain-of-custody records.
Questions brands ask us
Does this replace our serialization / track-and-trace?
No — it complements it. TAGUARD adds a consumer-verifiable authentication layer and real-time temperature evidence on top of regulatory serialization.
Is it suitable for low-infrastructure export markets?
Yes. Verification needs only a smartphone tap, which is ideal where dedicated scanners aren't available across the last mile.
Protect patients and your brand
Tell us your product and markets — we'll scope an authentication + cold-chain PoC for your line.